Olipop is a private company building in food & beverage, founded in 2018. The latest valuation stands at $1.9B (post-money). No public ticker exists for the company.
1 valuation. The latest, $1.9B post-money, was set by the Series C in Feb 2025.
OLIPOP makes a prebiotic soda sold in over 65,000 US retailers, formulating each can around its proprietary OLISMART fiber and botanical blend to support digestive and microbiome health while keeping sugar to 2-5 grams. Co-founders Ben Goodwin and David Lester built the brand on the idea of recreating classic soda flavor without the downsides of conventional soft drinks, and Goodwin continues to lead formulation as CEO. The company works with a scientific advisory board of gut-microbiome researchers from institutions including Purdue University, Baylor College of Medicine and the University of Nottingham to guide its ingredient research.
OLIPOP is a public benefit corporation and counts Gwyneth Paltrow and Mindy Kaling among its investors.
Listed funds carry late-stage private names. A fund's latest schedule of investments shows whether it holds Olipop.
Often trade at a premium or discount to NAV.
Platforms match existing holders with buyers. Olipop availability at any moment is set by the holders.
High minimums, transfer approval, company right-of-first-refusal.
Valuations, rounds and IPO status for every company in the directory — Olipop included.
The routes section explains what is realistically available for a company at this stage.
No. Olipop is a private company; its shares do not trade on a public exchange.
The last valuation is $1.9B (post-money, Feb 2025).
Lead investors for each round are in the funding timeline.
The closest food & beverage peers are on the competitors page.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
